FSMAX
Price
$94.93
Change
-$0.10 (-0.11%)
Updated
Aug 5 closing price
Net Assets
39.63B
IBSSX
Price
$17.34
Change
-$0.54 (-3.02%)
Updated
Aug 5 closing price
Net Assets
277.99M
Interact to see
Advertisement

FSMAX vs IBSSX

Header iconFSMAX vs IBSSX Comparison
Open Charts FSMAX vs IBSSXBanner chart's image
Fidelity Extended Market Index
Price$94.93
Change-$0.10 (-0.11%)
VolumeN/A
Net Assets39.63B
VY® Baron Growth S
Price$17.34
Change-$0.54 (-3.02%)
VolumeN/A
Net Assets277.99M
FSMAX vs IBSSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. IBSSX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and IBSSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.6B vs. IBSSX (278M). FSMAX pays higher dividends than IBSSX: FSMAX (0.46) vs IBSSX (0.00). FSMAX was incepted earlier than IBSSX: FSMAX (14 years) vs IBSSX (23 years). IBSSX (1.37) is less costly to investors than FSMAX (0.04). FSMAX is a more actively managed with annual turnover of: 9.00 vs. IBSSX (4.00). FSMAX (0) and IBSSX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 21.86 vs. IBSSX (-18.43). FSMAX return over 5 years is better than : 52.00 vs. IBSSX (-24.28).
FSMAXIBSSXFSMAX / IBSSX
Total Expense Ratio0.041.253%
Annual Report Gross Expense Ratio0.041.373%
Fund Existence14 years23 years-
Gain YTD4.566-23.834-19%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets39.6B278M14,245%
Annual Yield % from dividends0.460.00-
Returns for 1 year21.86-18.43-119%
Returns for 3 years38.84-19.92-195%
Returns for 5 years52.00-24.28-214%
Returns for 10 years84.21-38.82-217%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LE13.130.46
+3.63%
Lands' End
HALO60.810.82
+1.37%
Halozyme Therapeutics
CHSCP28.590.07
+0.23%
CHS
ICCC6.18-0.06
-0.96%
ImmuCell Corp
SRPT16.75-0.35
-2.05%
Sarepta Therapeutics